Publications

Pharmacogenomics Reveals Erbb2 As A Therapeutic Target In Primary Ependymoma Cultures

AuthID
P-00Q-SY6

Author(s)

Pauck, D

Sarikaya Seiwert, S

Marquardt, V

Paisana, E

Picard, D

Bartl, J

Bluemel, L

Maue, M

Dimitriadis, C

Taban, K

Fischer, U

Steiger, HJ

Faria, C

Reifenberger, G

Borkhardt, A

Beez, T

Remke, M

Document Type

Abstract

Year published

2019

Published

in NEURO-ONCOLOGY, ISSN: 1522-8517

Volume: 21, Pages: 78-79 (2)

Conference

5Th Biennial Conference of the Society-For-Neuro-Oncology on Pediatric Neuro-Oncology Basic and Translational Research, Date: MAY 03-04, 2019, Location: San Francisco, CA, Sponsors: Soc Neuro Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/neuonc/noz036.065

Wos: WOS:000473243700066

Source Identifiers

ISSN: 1522-8517

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Pharmacogenomics Reveals Erbb2 As A Therapeutic Target In Primary Ependymoma Cultures

Useful Links

Get Help

Federated Authentication (Click on the image)

Pharmacogenomics Reveals Erbb2 As A Therapeutic Target In Primary Ependymoma Cultures

Useful Links

Get Help